Dr. Joseph Geoffery Cheatham, MD

Dr. Cheatham practices at Scripps Medical Center Jefferson in Oceanside, California.

Dr. Cheatham's NPI, 1700948494, was assigned on December 15, 2006. Dr. Cheatham graduated from Loma Linda University School of Medicine in 2003. Dr. Cheatham holds Virginia license 0101238048.

Dr. Cheatham's primary practice is Scripps Medical Center Jefferson, at 2205 Vista Way, Oceanside, CA 92054 in San Diego County. The practice phone is (760) 704-5400.

Dr. Cheatham's primary practice is Scripps Medical Center Jefferson in Oceanside, California. Dr. Cheatham is also affiliated with Scripps Green Hospital. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Cheatham to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheatham practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Cheatham's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Cheatham is licensed in Virginia.

CMS data shows 347 Medicare services from Dr. Cheatham across 6 procedure codes in 2024, for 191 Medicare patients. Medicare paid $33,115 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Cheatham in 2024. The largest group is 65 to 74, with 143 patients. 69% of them have high cholesterol, and 51% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cheatham's median patient age at 57, with 54% women.

In 2024, Dr. Cheatham wrote 132 Medicare Part D claims for 127 patients. 79% of them were for generic drugs. CMS names the drug for 114 of them, across 1 drug with 11 or more claims each, at $7,693 in total drug cost. In 2023, CMS named 140 claims across 3 drugs.

Dr. Cheatham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Cheatham, more than 49% of the clinicians it reports for that procedure.

Dmand AI links Dr. Cheatham to 1 clinical trial. Conditions studied include Colitis, Ulcerative and Colitis. Open Payments lists research payments to Dr. Cheatham that name 1 trial.

CMS Open Payments shows 7 general payments to Dr. Cheatham from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $182. It also lists 1 research payment totaling $655 in 2018, naming 1 clinical trial.

Dr. Cheatham graduated from Loma Linda University School of Medicine in 2003.